A once-monthly treatment for opioid use disorder
The Lancet in conversation with
English - February 18, 2019 16:00 - 12 minutes - 8.38 MBLife Sciences Science Education medicine research covid diseases science health care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Advancing women in science, medicine, and global health
Next Episode: Inter-pregnancy interval after stillbirth
Mark Greenwald discusses buprenorphine extended release—a once-monthly injected formulation for the treatment of opioid use disorder recently approved by the US FDA.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv